Journal article

Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance

Robert Weinkove, Zoe K McQuilten, Jonathan Adler, Meera R Agar, Emily Blyth, Allen C Cheng, Rachel Conyers, Gabrielle M Haeusler, Claire Hardie, Christopher Jackson, Steven W Lane, Tom Middlemiss, Peter Mollee, Stephen P Mulligan, David Ritchie, Myra Ruka, Benjamin Solomon, Jeffrey Szer, Karin A Thursky, Erica M Wood Show all



INTRODUCTION: A pandemic coronavirus, SARS-CoV-2, causes COVID-19, a potentially life-threatening respiratory disease. Patients with cancer may have compromised immunity due to their malignancy and/or treatment, and may be at elevated risk of severe COVID-19. Community transmission of COVID-19 could overwhelm health care services, compromising delivery of cancer care. This interim consensus guidance provides advice for clinicians managing patients with cancer during the pandemic. MAIN RECOMMENDATIONS: During the COVID-19 pandemic: In patients with cancer with fever and/or respiratory symptoms, consider causes in addition to COVID-19, including other infections and therapy-related pneumonitis..

View full abstract